Aim of the study: Schizophrenia is a major psychiatric disorder, imparting a major burden in health care sector. Many treatments are available now a days to treat schizophrenia, although, its burden is not decreasing. The main reason behind this is noncompliance to treatment. This study aims to find out the noncompliance prevalence and to study influence of sociodemographic factors, treatment related variables, illness related variables and various subjective reasoning in patients with schizophrenia.
INTRODUCTION
Schizophrenia is a clinical syndrome of variable, but profoundly disruptive psychopathology that involves cognition, emotion, perception, and other aspects of behavior [1] . The etiology is multifactorial [2] . The typical age of on-set for schizophrenia is in late adolescence or early twenties, with a slightly later onset in females. An earlier age at onset has been associated with more severe clinical and behavioral symptoms, more social disability, narrower posterior brain segments and larger ventricles [3] . The 12 months prevalence of Schizophrenia is 1.1%. The total 12-month healthcare use in any type of health service sector is 64.3% in patients affected with Schizophrenia [4] . Schizophrenia rank fifth among men and sixth among women as a leading cause of years lived with disability. Schizophrenia also comprises roughly 1% of the global burden of disease (GBD). They also represent 1.3% of the disability-adjusted life years (DALYs) overall [5] . The classic course of schizophrenia remains chronic with multiple exacerbations and remissions. Most schizophrenia patients' life is characterized by aimlessness, inactivity, frequent hospitalizations, homelessness and poverty [6] . The prognosis is guarded and full recovery is unusual. Early onset of illness, family history of schizophrenia, structural brain abnormalities, and prominent cognitive symptoms are associated with a poor prognosis [7] . People with schizophrenia have a 5% lifetime risk of suicide. Other factors that contribute to increased mortality include lifestyle issues such as cigarette smoking, poor nutrition, and lack of exercise, and perhaps poorer medical care and complications of medications [8] .
Compliance is the degree to which a patient correctly follows medical advice, which includes medication or drug use, medical device use, selfcare, self-directed exercises, or therapy sessions [9] . Noncompliance can be defined as a discontinuation or failure of proper medication intake without prior approval from the treating physician. Non-compliance with the treatment is a major problem in case of psychiatric patients [10] DSM-5 [11] has also mentioned this issue of noncompliance to an important category as "nonadherence to medical treatment" under the heading "other conditions that may be a focus of clinical attention".
Schizophrenia by its chronic course, impairs judgment, insight and stability which place schizophrenic patients at increased risk for medication non-compliance. Non-compliance is considered as a barrier to effective health care, has implications for the health of the patients; the effective use of resources & assessments of the clinical efficacy of treatment. It is seen as an important area of concern for all health care professionals. Non-compliance contributes to relapse and re-hospitalization. The cost of poor compliance to sufferers and also to society is considerable and effective ways of improving compliance are a crucial part of good management [10] .
Multiple studies [12] [13] [14] [15] has shown that the prevalence of noncompliance is 30%-50%. They have also shown various factors which influence the compliance to treatment which includes relationship with psychiatrist, family pressure for taking medications, stigma of illness, and substance abuse, severity of illness, access to treatment and medications, financial situation, age at onset, employment, side effects of medication etc.
Attitude towards antipsychotic medication is affected by various factors such as lack of insight into the illness, presence of global functioning, increased severity of illness and side effects of medications.
Improving medication compliance in persons who are mentally ill is important for reducing morbidity and suffering of patients and their families. Thus, to improve drug compliance in any treatment setting, first it is necessary to know the factors influencing the compliance. Literature regarding the treatment compliance in Schizophrenia is sparsely available in India and other developing countries.
With this background in present study, we have attempted to find out the prevalence of noncompliance and various factors influencing the treatment in patients with Schizophrenia.
METHODS
The study was conducted in Department of Psychiatry of a tertiary care hospital. After taking approval from IEC of our institute, over the period of 1 year (March'14 to March'15), from the patients attending Psychiatry department at IPD or OPD, patients suffering from Schizophrenia who fulfilled inclusion criteria were included in present study. They were explained about the study and written informed consent was taken. In our center,case history and treatment details are recorded on a case paper which is given to patient, which they bring with them in follow up visits. The follow up visits are decided by the treating doctor according to the patient's clinical condition. We also insist to come with relatives, but at times patients come alone. We prefer providing same treating doctor for ensuring a good rapport with the treating psychiatrist, still patient has a right to choose the doctor. Proper care has been taken for not violating the ethical duties related to patient's identities, treatment and therapeutic relations between therapist and the patients. 
Assessment of patient:
Socio-demographic details: Patients' socio-demographic details included age, sex, residence, education, occupation, marital status, family type and socio-economic status. Their socio-economic status was defined according to modified Prasad's classification 16 for socio economic status for 2013. Compliance: The compliance was assessed by clinician's judgement. For the ease of understanding we have grouped patients in 4 groups. 0: Up to 1 week without medication otherwise good compliance(compliant) 1: Up to 1 month /4 times up to 1 week without medication 2: Up to 5 months without medication 3: >5 Months without medication Illness details: This domain included details of patients' illness like age at onset of illness, total duration of illness, insight during the episode, severity of illness, comorbid substance use and presence of comorbidities. The severity of illness was defined by positive and negative syndrome scale for Schizophrenia (PANSS) 17 scale. The PANSS is a 30-item, 7-point rating instrument. Pearson correlation for positive, negative and general psychopathology scale was .80, .68 and .60, respectively (p < .001). The reliability was not significant in composite scale (.07).
Treatment details: This part included the details of treatment including type of molecules used, monotherapy or polytherapy, drug dosage frequency, route of administration, total number of tablets per day, approximate monthly cost for the treatment and side effects if any.
Subjective reasons for compliance and noncompliance: The rating of medication influences (ROMI) [18] scale was developed as part of a longitudinal study of Neuroleptic noncompliance in Schizophrenia. It takes 20-30 minutes to administer. The patient-report items includes three subscales related to compliance (prevention, influence of others, and medication affinity) and five subscales related to noncompliance (denial/dysphoria, logistical problems, rejection of label, family influence, and negative therapeutic alliance). ROMI is divided in two parts:1) Semi-structured interview: It includes information regarding living, treatment setting, prescribed medication, patient's overall attitude toward treatment and medication, the family's and caregiver's overall attitude toward treatment and medication. 2) Structured interview: It includes two type of questions i.e., open ended and closed. It is divided into two parts: the reasons for compliance section (items 1-7) and the reasons for noncompliance section (items [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Response to each closed question is graded as "no influence", "mild influence" and "strong influence" (1, 2 and 3, respectively, or 9 when it is not possible to evaluate the degree of influence).
The collected data was subjected to statistical analysis by using SPSS16. Chi-square test was used to find out statistical significance of variables in influencing compliance. The p value of less than or equal to 0.05 was used as a cut off for measuring significance In the current study, 37.5% patients with schizophrenia were noncompliant. Present study found that from the various socio-demograph-ic variables, education was the significant factor in influencing compliance. Literate patients were more compliant than illiterate. Among the various illness related variables, this study found that the severity of illness (PANSS score) is significantly associated with the treatment compliance. Present study found the total positive symptoms score, total general psychopathology symptom score and total PANSS score to be significantly associated with compliance. Present study found that the type of regimen i.e., monotherapy or polytherapy and the dosing frequency of medication are significant in influ-encing the compliance. The patients receiving monotherapy and receiving drugs once or twice in a day were more compliant. On assessing the subjective reasons for maintaining compliance and not maintaining compliance by using ROMI scale, the 3 major reasons for maintaining compliance in this present study were: 1. Perceived daily benefit with med-ication, 2. Acceptance of mental illness and 3. Family force or belief. The compliant patients reported that no need of medication currently and feeling of cured can be their probable reason for noncompliance in majority instances.
RESULTS
The leading reasons for noncompliance in noncompliant patients were: 1. Medicines are unnecessary, 2. Access problems, 3. Financial problems, 4. No perceived benefit with medication and 5. Embarrassment or stigma related to illness. The "perceived daily benefit" variable had shown the statistical significance in relation to compliance. It is showing that majority of patients (87%) were without medication since 1-5 months; most of them scored at lower range in PANSS and had grade 3 of insight in their illness. On statistical analysis, illness severity was found to be significantly (p < 0.05) related to grade of noncompliance.
DISCUSSION
Present study had included 80 patients who gave written informed consent for enrolling in study, of which 30 (37.5%) were noncompliant. Shakeel Ansari et al [12] (37%) and R Baby et al [13] (38.7%) found similar results. Other studies like, T.N. Srinivasan et al, 19 K.Kousalya et al [20] Chandra IS et al, 14 N J B Kazadi et al [21] have found higher rates ranging from 42-80%. The reason for the difference may be the regional differences. Although, it is important observa-tion that the rates are on higher range which is hindering the prognosis.
In the present study education was found to be the only socio demographic variable significantly affecting the treatment compliance. These results are similar to R Baby et al., [13] Hudson et al. [22] , Janssen et al. [23] Linden M et al. [24] and Aldebot S et al. [25] the possible explanation for this is the negative relation of lower education with treatment compliance. Education help people understand the explanation given for the importance of compliance and thus help in maintaining it well. On the contrary, other studies reported significance of some other variables; Shakeel Ansari et al [12] and Chandra IS et al [14] reported gender & residential area and age & employment respectively as variables which are associated significantly with treatment adherence. This difference is may be because of less diversity in this socio demographic variables in our group of patients. Meguid et al [27] reported significant relation between all PANSS score and compliance. The R Baby et al. [13] reported only total positive symptoms score to be significantly correlated to noncompliance while study [14] done by Chandra IS and colleagues reported only total PANSS score as a significant variable to be associated with noncompliance. These finding are similar to our study. The reason for this may be because of negative effect of illness severity on understanding the nature of illness and importance of treatment. There are reports of no relation between illness severity and compliance [24] and significant relation between compliance and only negative symptoms score [26] , which is contrary to our study's findings.
Linden M et al. [24] reported that there is no relation between insight and compliance. R Baby et al. [13] found that substance use, comorbid physical conditions and total duration of illness are not significantly related to compliance. these results are similar to our study. On the contrary, Shakeel Ansari et al [12] reported substance use as significantly affecting the treatment compliance. This contradiction may be because of the fear of the patients that treating psychiatrist could tell their family about their abuse which may worsen their relationship with them. Information related to substance abuse was taken only as subjective report, no objective assessment was done for the same.
Insight has been found a significant factor to be associated with compliance by many studies [13, 28, 29, 30] . It is obvious that the lack of insight in illness can impair the compliance but the different finding of our study explains that the patients in our study are maintaining compliance without proper insight in the illness. This indicates the need for improvising the education given to the patient regarding the insight in the illness. This can further improve the compliance rates in our center. R Baby et al. [13] has reported that there is no significant relation between total number of medication, approximate cost of treatment, type of molecules, presence of side effects or route of administration and treatment compliance. J.Meier et al. [31] found the dosing frequency to be a significant factor in influencing the compliance. This result is similar to our study. It is obvious that the lesser the number of drugs per day and the less frequent is the dose, it is easy to remember and sticking to the prescription. Mc-Cann T. et al [32] reported side effects are not significant in altering treatment compliance. The type of molecule particularly atypical neuroleptic has been considered superior than typical ones in terms of better adherence by Janssen et al. [23] ; particularly when switched from typical to atypical molecules rather than maintained on typical molecules. This may be because of lesser side effects with the newer atypical molecules.
Previously various studies have studied the subjective reasons for compliance using ROMI. Majority patients included in this study were living in rural region and not having a good employment. This explains the access problem to the center and financial difficulty as one of the important reasons for noncompliance. In Indian culture, Family plays a significant role. Many patients reported that they are maintaining compliance because of family force or belief. So, it is important for the mental health professionals to educate the family members regarding the illness and the need for treatment. The perceived benefit because of drugs is important reason given by the compliant patient for compliance, this explains that the treating psychiatrist should access this more vigorously in each follow up visit to understand it and can do the needful accordingly. the compliant patients reported that the feeling of cured give them a thought to break the compliance, this should be prevented by frequent explanation regarding course, prognosis and need for the long term treatment for the patients who are maintaining a good compliance. Studies like R Baby et al [13] Shakeel Ansari et al [12] Chandra IS et al [14] found the similar results as the present study. Loffler et al [33] and Rosa et al [34] has reported "inconvenience due to side effects" as the important reason for noncompliance in addition to above mentioned reasons. this may be because the patients in our study may not be well aware of minor side effects and they have tolerated them on their own. this explains the need for a thorough explanation of side effects to the patients by treating professional.
CONCLUSION
The present study has assessed various factors affecting compliance in patients with schizophrenia. The study finds a need for a vigorous work up for addressing the issue of compliance in a chronic illness like schizophrenia. For our center we found that treating psychiatrist can help in improving compliance by frequent psycho-education of patients and family members about the illness and the need for treatment, by keeping the regimen as simple as possible, by prescribing medication in a single time dosing, by controlling the acute illness as soon as possible and in many other ways. We also find the need for extending services to the interior areas that can cut down the access problems the patients facing for maintaining the compliance. improving compliance can greatly reduce the disease burden and thus can improve the quality of life of patients and their family members.
Merits of the study
A good sample size of the study makes the results more validated. All the tools used in the study have a strong validity and reliability. Study results gave the important areas related to noncompliance which can be addressed by the psychiatrists with a good emphasis; eventually all these can help in improving compliance and reducing the relapse rates related to medication noncompliance.
Limitations of the study
Being a single center hospital based study, the results cannot be generalized. The best possible efforts were made while applying the tools in the local language, still there may be language bias affecting the study quality.
Future perspective
This type of research should be conducted in each mental health services to explore the prevalence of non-compliance and to find out particular reasons for the same. This can help in overall reduction in disease burden and overall improvement in health care delivery.
